Simplex Trading
PSTX

Simplex Trading’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Simplex Trading’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,800
Closed -$25K – 9894
2024
Q3 		$25K Sell
8,800
-6,200
-41% -$19.2K ﹤0.01% 6512
2024
Q2 		$43K Buy
15,000
+11,300
+305% +$30.9K ﹤0.01% 6236
2024
Q1 		$11K Sell
3,700
-1,500
-29% -$5K ﹤0.01% 7575
2023
Q4 		$17K Buy
5,200
+2,100
+68% +$5.41K ﹤0.01% 7067
2023
Q3 		$7K Buy
3,100
+2,000
+182% +$4.19K ﹤0.01% 7483
2023
Q2 		$1K Sell
1,100
-2,100
-66% -$5.36K ﹤0.01% 8768
2023
Q1 		$9K Buy
3,200
+1,700
+113% +$10.2K ﹤0.01% 7669
2022
Q4 		$7K Buy
1,500
+400
+36% +$1.83K ﹤0.01% 7876
2022
Q3 		$3K Buy
+1,100
New +$3.64K ﹤0.01% 9174
2022
Q1 		– Sell
-2,000
Closed -$13K – 11602
2021
Q4 		$13K Buy
+2,000
New +$13.6K ﹤0.01% 8823
2021
Q1 		– Sell
-4
Closed -$4K – 10269
2020
Q4 		$4K Buy
+4
New +$42 ﹤0.01% 7826

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Simplex Trading's PSTX Position: Q1 2025 in Review

Simplex Trading sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 14,032 shares — an estimated $134K sold.

Simplex Trading first reported a position in PSTX in Q4 2020 and held it in 9 quarters. The position peaked at $134K in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Simplex Trading reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 14,032 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $134K.
  • Simplex Trading first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Simplex Trading's Poseida Therapeutics, Inc. Common Stock position peaked at $134K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.